Takeda Pharmaceutical Co., Ltd. (TAK)

16.10 -0.06 (-0.37%) USD  |  NYSE  |  Jan 20, 11:15
More

Takeda Pharmaceutical EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TAK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Novartis AG Upgrade
Pfizer Inc. Upgrade
Sanofi Upgrade
Nxera Pharma Co., Ltd. Upgrade
Protagonist Therapeutics, Inc. Upgrade